J. Donnelly

发表

Ceftazidime Compared with Piperacillin and Tobramycin for the Empiric Treatment of Fever in Neutropenic Patients with Cancer: A Multicenter Randomized Trial

R. Feld, S. Deresinski, B. D. de Pauw, 1994, Annals of Internal Medicine.

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

D. Denning, J. Meis, J. Donnelly, 1998, The Journal of antimicrobial chemotherapy.

Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts

D. Denning, J. Donnelly, M. Cuenca‐Estrella, 2003 .

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).

D. Denning, F. Dromer, J. Rex, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Patricia Muñoz, Angela Restrepo, Raoul Herbrecht, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and Candidemia

J. Donnelly, M. Cuenca‐Estrella, J. Rodríguez-Tudela, 2007, Antimicrobial Agents and Chemotherapy.

Cochrane Database of Systematic Reviews Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people (Review)

Maertens, Johan, J. Loeffler, 2019 .

Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan

J. Meis, J. Donnelly, P. Verweij, 1997, Journal of clinical microbiology.

In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates

J. Meis, J. Donnelly, P. Verweij, 2002, Antimicrobial Agents and Chemotherapy.

Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease

R. Ebrahimi, J. Donnelly, R. Herbrecht, 2011, Mycoses.

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure

J. Donnelly, A. Warris, P. Verweij, 2008, Journal of Clinical Microbiology.

A strategy for managing fungal infections in haematopoietic stem cell transplantation

J. Donnelly, 2000, Transplant infectious disease : an official journal of the Transplantation Society.

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗

D. Denning, F. Dromer, M. Arendrup, 2008 .

Therapeutic Drug Monitoring of Voriconazole

J. Donnelly, R. Aarnoutse, A. Warris, 2008, Therapeutic drug monitoring.

Serum C-reactive protein levels in the management of infection in acute leukaemia.

D. Catovsky, D. Galton, J. Goldman, 1984, European journal of cancer & clinical oncology.

Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.

T. Franquet, H. Einsele, L. Pagano, 2022, The Lancet. Infectious diseases.

Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens

W. Melchers, J. Loeffler, P. White, 2011, Journal of Clinical Microbiology.

Aspergillus PCR: One Step Closer to Standardization

W. Melchers, J. Loeffler, P. White, 2010, Journal of Clinical Microbiology.

Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study

J. Epstein, J. Raber-Durlacher, J. Donnelly, 2013, Supportive Care in Cancer.

Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy.

T. Feuth, J. Donnelly, N. Blijlevens, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Supportive Care in the Management of Leukaemia

J. Donnelly, A. Prentice, 2010 .

18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation

W. Oyen, B. Kullberg, J. Donnelly, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Perfect, H. Masur, A. Caliendo, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nucleic Acid Tools for Invasive Fungal Disease Diagnosis

L. Millon, J. Loeffler, V. Rickerts, 2020, Current Fungal Infection Reports.

Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips

J. Loeffler, P. White, J. Donnelly, 2018, Medical mycology.

Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

J. Wingard, J. Löffler, P. White, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Towards a standard for Aspergillus PCR - requirements, process and results

J. Loeffler, P. White, J. Donnelly, 2012 .

The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay.

W. Melchers, F. Hagen, J. Loeffler, 2019, Medical mycology.

Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy.

J. Donnelly, P. Verweij, N. Blijlevens, 2009, Diagnostic microbiology and infectious disease.

Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

J. Donnelly, N. Blijlevens, Thijs MP van Iersel, 2009, BMC medicine.

The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation

J. Donnelly, N. Blijlevens, W. J. van der Velden, 2008, Transplant infectious disease : an official journal of the Transplantation Society.

Infection Prevention – Protected Environment and Infection Control

J. Donnelly, 2011 .

Reply to Mafaciolli and Pasqualotto

J. Donnelly, J. Maertens, P. Verweij, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bronchoalveolar Lavage Fluid Galactomannan for Diagnosis of Invasive Pulmonary Aspergillosis

J. Donnelly, 2017 .

Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?

J. Donnelly, T. Rogers, M. Slavin, 2011, British journal of haematology.

Galactomannan detection and diagnosis of invasive aspergillosis.

J. Donnelly, Mariske M Leeflang, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

J. Donnelly, P. Verweij, M. A. Mennink-Kersten, 2004, The Lancet. Infectious diseases.

The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.

J. Löffler, P. White, C. Cordonnier, 2020, The Journal of antimicrobial chemotherapy.

Care pathways for managing invasive mould diseases.

J. Donnelly, 2013, International journal of antimicrobial agents.

Chemoprophylaxis for the prevention of bacterial and fungal infections.

J. Donnelly, 1995, Cancer treatment and research.

How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation

J. Donnelly, G. Maschmeyer, 2016, British journal of haematology.

Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients

J. Donnelly, N. Blijlevens, A. Herbers, 2008, Bone Marrow Transplantation.

A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients

A. Naber, J. Donnelly, A. Schattenberg, 2005, Supportive Care in Cancer.

Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.

M. Netea, A. Cook, B. Kullberg, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species

M. Arendrup, G. Kahlmeter, J. Donnelly, 2009, Antimicrobial Agents and Chemotherapy.

PCR-Based Methods with Aspergillosis as a Model

J. Löffler, J. Donnelly, R. Barnes, 2008 .

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

M. Bassetti, C. Viscoli, B. Kullberg, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prophylaxis and aspergillosis--has the principle been proven?

B. D. de Pauw, J. Donnelly, 2007, The New England journal of medicine.

Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?

J. Donnelly, 1997, Journal of internal medicine. Supplement.

European expert opinion on the management of invasive candidiasis in adults.

J. Vincent, J. Meis, T. Calandra, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.

M. Netea, G. Adema, T. Feuth, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

M. Paesmans, L. Ameye, M. Bassetti, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring myeloablative therapy‐induced small bowel toxicity by serum citrulline concentration

P. Lambin, N. Deutz, B. D. de Pauw, 2005, Cancer.

A scoring system for the assessment of oral mucositis in daily nursing practice.

T. van Achterberg, T. Feuth, J. Donnelly, 2006, European journal of cancer care.

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

J. Donnelly, P. Verweij, A. Rijs, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Specimens in Whole-Blood Aspergillus fumigatus Critical Stages of Extracting DNA from

W. Melchers, J. Loeffler, P. White, 2014 .

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients

B. D. de Pauw, J. Donnelly, N. Blijlevens, 2002, British journal of haematology.

Two strategies for managing invasive aspergillosis: a decision analysis.

J. Severens, J. Meis, P. F. De Vries Robbé, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Duration of Antifungal Treatment and Development of Delayed Complications in Patients with Candidaemia

J. Meis, J. Meer, B. Kullberg, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

When to change treatment of acute invasive aspergillosis: an expert viewpoint

Yee-Chun Chen, F. Marty, J. Rex, 2021, The Journal of antimicrobial chemotherapy.

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

S. Seyedmousavi, D. Denning, A. Chowdhary, 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Antimicrobial therapy to prevent or treat oral mucositis.

S. Sonis, J. Epstein, J. Donnelly, 2003, The Lancet. Infectious diseases.

Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia

B. D. de Pauw, J. Donnelly, P. Verweij, 1997, Annals of Hematology.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Species Aspergillus Testing of Colorimetric Assay for Antifungal Susceptibility

J. Donnelly, P. Verweij, J. Meletiadis, 2001 .

Comparison of NCCLS and 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method

J. Donnelly, P. Verweij, J. Meletiadis, 2000, Journal of Clinical Microbiology.

Determining mucosal barrier injury to the oesophagus using CT scan

Derya Yakar, J. Donnelly, N. Blijlevens, 2007, Supportive Care in Cancer.

Mucosal Barrier Injury and Infections

J. Donnelly, N. Blijlevens, 2011 .

Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease.

J. Donnelly, N. Blijlevens, A. D. de Haan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

J. Donnelly, N. Blijlevens, Thijs MP van Iersel, 2009, BMC medicine.

Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy

J. Donnelly, A. Schattenberg, N. Blijlevens, 2004, Bone Marrow Transplantation.

Procalcitonin Does Not Discriminate Infection from Inflammation after Allogeneic Bone Marrow Transplantation

J. Meis, B. D. de Pauw, J. Donnelly, 2000, Clinical Diagnostic Laboratory Immunology.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Editorial: A new Editor-in-Chief and the 40th anniversary of the Journal of Antimicrobial Chemotherapy.

J. Donnelly, 2015, The Journal of antimicrobial chemotherapy.

EUCAST technical note on fluconazole.

D. Denning, M. Arendrup, A. Velegraki, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis.

J. Meis, B. D. de Pauw, J. Donnelly, 1995, Clinical Infectious Diseases.

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study.

J. Raemaekers, I. Nováková, B. D. de Pauw, 1993, Leukemia & lymphoma.

Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients.

R. Sauerwein, B. D. de Pauw, J. Donnelly, 1993, Scandinavian journal of infectious diseases.

A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients.

J. Donnelly, P. Muus, A. Schattenberg, 1992, Bone marrow transplantation.

Can anything be done about oral mucositis?

C. Verhagen, J. Donnelly, N. Blijlevens, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIA

D. Catovsky, J. Goldman, J. Cohen, 1983, The Lancet.

Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.

B. Franke, J. Donnelly, P. Troke, 2010, Journal of Antimicrobial Chemotherapy.

Pre-emptive administration of corticosteroids prevents the development of ARDS associated withStreptococcus mitis bacteremia following chemotherapy with high-dose cytarabine

J. Donnelly, J. Raemaekers, B. Pauw, 1994, Annals of Hematology.

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.

B. D. de Pauw, J. Donnelly, N. Blijlevens, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Halo sign and improved outcome.

L. V. van Die, J. Donnelly, P. Verweij, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.

M. Netea, B. Kullberg, B. Tai, 2013, The Journal of antimicrobial chemotherapy.

New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies

J. Donnelly, T. Patterson, 2019, Journal of fungi.

NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation

J. Jansen, T. Feuth, J. Donnelly, 2009, Bone Marrow Transplantation.

Title International expert opinion on the management of infection caused byazole-resistant Aspergillus fumigatus

J. Donnelly, A. Groll, D. Andesc, 2019 .

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

C. Heussel, M. Vehreschild, C. Cordonnier, 2017, The Journal of antimicrobial chemotherapy.

Differences in T cell depletion and intestinal mucositis explain inconsistent effects of NOD2/CARD15 polymophisms in SCT.

J. Donnelly, N. Blijlevens, W. J. van der Velden, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serial monitoring ofAspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples

J. Meis, J. Donnelly, P. Verweij, 1997, Infection.

An overview of using fungal DNA for the diagnosis of invasive mycoses

L. Millon, F. Hagen, P. White, 2022, Expert review of molecular diagnostics.

Host-microbe interactions in stem cell transplantation; recognizing Candida in infection and inflammation

M. Netea, T. Plantinga, B. Kullberg, 2010, Virulence.

Recognizing Candida in infection and inflammation

M. Netea, T. Plantinga, B. Kullberg, 2010 .

Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.

D. Catovsky, J. Goldman, J. Darrell, 1984, The Journal of hospital infection.

Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation

J. Donnelly, N. Blijlevens, P. Peer, 2014, Bone Marrow Transplantation.

Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder

J. Donnelly, P. Verweij, N. Blijlevens, 2006, Annals of Hematology.

Analytical Comparison of In Vitro-Spiked Human Serum and Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative

W. Melchers, J. Springer, J. Loeffler, 2015, Journal of Clinical Microbiology.

Human platelets attenuate Aspergillus species via granule-dependent mechanisms.

M. Dierich, J. Donnelly, C. Lass‐Flörl, 2008, Journal of Infectious Diseases.

The Role of Itraconazole in Preventing and Treating Systemic Fungal Infections in Immunocompromised Patients

M. Potter, J. Donnelly, 2004, Acta Haematologica.

Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient

J. Meis, B. D. de Pauw, J. Donnelly, 1996 .

Erratum: The European Committee on antimicrobial susceptibility testing - Subcommittee on antifungal susceptibility testing (EUCAST-AFST)*. EUCAST technical note on fluconazole (Clinical Microbiology and Infection (2008) vol. 14(2) (193-195))

D. Denning, M. Arendrup, A. Velegraki, 2009 .

Measuring mucosal damage induced by cytotoxic therapy

J. Donnelly, N. Blijlevens, B. Pauw, 2004, Supportive Care in Cancer.

EUCAST technical note on posaconazole.

M. Arendrup, J. Donnelly, M. Cuenca‐Estrella, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Role of the mycobiome in human acute graft-versus-host disease.

M. Netea, G. Huls, J. Donnelly, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.

J. Donnelly, C. Knibbe, N. Blijlevens, 2014, The Journal of antimicrobial chemotherapy.

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

B. D. de Pauw, J. Donnelly, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Colorimetric Assay for Antifungal Susceptibility Testing ofAspergillus Species

J. Donnelly, P. Verweij, J. Meletiadis, 2001, Journal of Clinical Microbiology.

The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole.

D. Denning, M. Arendrup, A. Velegraki, 2009 .

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

D. Denning, J. Meis, D. Stevens, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

J. Donnelly, J. Mouton, A. V. van Vliet, 2006, Antimicrobial Agents and Chemotherapy.

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

J. Meis, B. Kullberg, J. Donnelly, 1995, Annals of Hematology.

Comparison of methods for the interpretation of disk diffusion susceptibility tests for augmentin.

J. Donnelly, 1986, Diagnostic microbiology and infectious disease.

High-dose itraconazole for the treatment of cerebral aspergillosis.

J. Meis, J. Donnelly, P. Verweij, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Can We Achieve Clinical Breakpoints for the Triazoles in Aspergillosis?

M. Arendrup, J. Donnelly, M. Cuenca‐Estrella, 2011 .

Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.

D. Denning, M. Arendrup, A. Velegraki, 2009 .

Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.

B. D. de Pauw, J. Donnelly, A. Schattenberg, 1988, Bone marrow transplantation.

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

J. Meis, B. Kullberg, J. Donnelly, 1994, Infection.

Reliability of clinical research on invasive fungal infections: a systematic review of the literature.

L. Collette, B. D. de Pauw, J. Donnelly, 2001, Medical mycology.

Infections in Neutropenic Cancer Patients

J. Donnelly, G. Maschmeyer, V. Krĕméry, 1994 .

Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study

F. Bouwman, W. Melchers, J. Donnelly, 2018, The Journal of antimicrobial chemotherapy.

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.

J. Donnelly, K. Theunissen, J. van Eldere, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go.

J. Donnelly, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis.

J. Loeffler, C. Mengoli, J. Donnelly, 2009, The Lancet. Infectious diseases.

Triggers for driving treatment of at-risk patients with invasive fungal disease.

G. Rahav, J. Donnelly, Ľ. Drgoňa, 2013, The Journal of antimicrobial chemotherapy.

Statistical Analyses of Correlation between Fluconazole MICs for Candida spp. Assessed by Standard Methods Set Forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)

D. Denning, M. Pfaller, P. Warn, 2006, Journal of Clinical Microbiology.

A 2 ) Antimicrobial Susceptibility Testing ( E . Dis . by the European Committee on Assessed by Standard Methods Set Forth spp . Candida Fluconazole MICs for Statistical Analyses of Correlation between

D. Denning, M. Pfaller, P. Warn, 2006 .

Options and limitations of teicoplanin in febrile granulocytopenic patients

I. Nováková, B. D. de Pauw, J. Donnelly, 1990, British journal of haematology.

Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species.

J. Meis, B. D. de Pauw, J. Donnelly, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Perspectives on cancer therapy‐induced mucosal injury

L. Elting, E. Rubenstein, B. Bekele, 2004, Cancer.

Aspergillus infections: problems in diagnosis and treatment.

J. Meis, B. D. de Pauw, J. Donnelly, 1996, Infectious agents and disease.

Genetic variants and the risk for invasive mould disease in immunocompromised hematology patients

J. Donnelly, N. Blijlevens, N. Blijlevens, 2011, Current opinion in infectious diseases.

The role of antifungal treatment in hematology

J. Donnelly, J. Maertens, M. Nucci, 2012, Haematologica.

Microbiologic consequences of new approaches to managing hematologic malignancies.

B. D. de Pauw, J. Donnelly, N. Blijlevens, 2005, Reviews in clinical and experimental hematology.

Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients

J. Meis, A. Voss, B. D. de Pauw, 1997, Journal of clinical microbiology.

Reply to Herbrecht et al

J. Baddley, J. Donnelly, P. Pappas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Defining Invasive Aspergillosis: What the Revised EORTC/MSG Definitions Have in Store

J. Donnelly, 2009 .

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

J. Loeffler, C. Mengoli, J. Donnelly, 2019, The Cochrane database of systematic reviews.

Febrile mucositis in haematopoietic SCT recipients

T. Feuth, J. Donnelly, N. Blijlevens, 2009, Bone Marrow Transplantation.

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.

J. Donnelly, S. Daenen, G. Maschmeyer, 1992, European journal of cancer.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

H. Einsele, S. Iacobelli, A. Tomaszewska, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Introduction and Aims

J. Donnelly, 2020, The Origin of Higher Clades.

The end of the road for empirical antifungal treatment?

J. Donnelly, J. Maertens, 2013, The Lancet. Infectious diseases.

Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model

W. Melchers, B. Wickes, J. Loeffler, 2016, Journal of Clinical Microbiology.

Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative

W. Melchers, J. Springer, J. Loeffler, 2015, Journal of Clinical Microbiology.

Development and Evaluation of a Calibrator Material for Nucleic Acid-Based Assays for Diagnosing Aspergillosis

A. Caliendo, G. Lyon, B. Alexander, 2013, Journal of Clinical Microbiology.

Challenges and progress in setting a standard for PCR for invasive aspergillosis

J. Donnelly, R. Barnes, J. Loeffler, 2008 .

Editorial: Celebrating 40 years of the Journal.

J. Donnelly, 2016, The Journal of antimicrobial chemotherapy.

Commentary Commentary on the MAFF technical report: a review of antimicrobial resistance in the food chain

J. Donnelly, 1999 .

Host Impairments in Patients with Neoplastic Diseases

J. Donnelly, N. Blijlevens, W. J. van der Velden, 2014, Cancer treatment and research.

Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group.

L. Millon, F. Hagen, F. Morio, 2020, Medical mycology.

Potential sites of infection that develop in febrile neutropenic patients.

I. Nováková, B. D. de Pauw, J. Donnelly, 1993, Leukemia & lymphoma.

High-dose meropenem in meningitis due to Pseudomonas aeruginosa

R. Sauerwein, J. Donnelly, B. D. Pauw, 1992, The Lancet.

Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.

J. Donnelly, P. Verweij, N. Blijlevens, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Role of curcumin and the inhibition of NF-κB in the onset of chemotherapy-induced mucosal barrier injury

J. Donnelly, S. Timal, N. Blijlevens, 2004, Leukemia.

Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.

B. D. de Pauw, J. Donnelly, K. Williams, 1986, The Journal of infection.

Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy

R. Feld, S. Deresinski, J. Donnelly, 1998, Infection.

Regional Variations in the Further Management of Neutropenic Patients already Receiving Empirical Antimicrobial Therapy

B. D. de Pauw, J. Donnelly, Elizabeth E. Lane-Allman, 2001, Hematology.

European Surveillance of Infections and Risk Factors in Cancer Patients

W. Hiddemann, J. Donnelly, X. Schiel, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient

B. D. de Pauw, J. Donnelly, J. Raemaekers, 1997, Journal of internal medicine. Supplement.

Controversies in the antibacterial treatment of patients with neutropenia: a matter of comprehension or apprehension?

B. D. de Pauw, J. Donnelly, 1997, Cancer investigation.

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.

M. Boogaerts, J. Donnelly, A. Goldstone, 1995, The Journal of antimicrobial chemotherapy.

Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy.

I. Nováková, B. D. de Pauw, J. Donnelly, 1993, Leukemia & lymphoma.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

H. Einsele, P. Hauser, W. Melchers, 2017, The Journal of antimicrobial chemotherapy.

OP-JANM160025 1264..1268

H. Einsele, P. Hauser, W. Melchers, 2017 .

Assessment and reporting of clinical trials of empirical therapy in neutropenic patients.

J. Donnelly, 1991, The Journal of antimicrobial chemotherapy.

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

I. Nováková, B. D. de Pauw, J. Donnelly, 1991, Antimicrobial Agents and Chemotherapy.

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients.

I. Nováková, B. D. de Pauw, J. Donnelly, 1990, The Journal of antimicrobial chemotherapy.

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

B. D. de Pauw, J. Donnelly, N. Blijlevens, 2000, Bone Marrow Transplantation.

Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell Transplantation

T. Feuth, J. Donnelly, N. Blijlevens, 2010, PloS one.

Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT

T. Feuth, J. Donnelly, N. Blijlevens, 2013, Bone Marrow Transplantation.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

N. Kearney, G. Lyman, M. Aapro, 2011, European journal of cancer.

Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia

R. Ariano, G. Harding, J. Donnelly, 2005, The Annals of pharmacotherapy.

Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.

R. Feld, S. Deresinski, B. D. de Pauw, 1996, European journal of cancer.

Bacterial complications of transplantation: diagnosis and treatment.

J. Donnelly, 1995, The Journal of antimicrobial chemotherapy.

Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.

Jonathan Y. Ito, D. Denning, J. Donnelly, 1992, Chemotherapy.

Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients

I. Nováková, J. Donnelly, B. Pauw, 1991, Annals of Hematology.

Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients

J. Donnelly, M. Hendriks, D. Burger, 2006, Bone Marrow Transplantation.

Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated

K. Sepkowitz, T. Palmore, D. Yokoe, 2009, Bone Marrow Transplantation.

Trends in the outcomes of Dutch haematological patients receiving intensive care support.

P. Pickkers, J. Donnelly, N. Blijlevens, 2014, The Netherlands journal of medicine.

Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities

S. Iacobelli, M. Aljurf, J. Donnelly, 2018, Bone Marrow Transplantation.

W. Stevens, J. Donnelly, T. Mori, 2013, Bone Marrow Transplantation.

Long-Term Health Related Quality of Life following Intensive Care during Treatment for Haematological Malignancies

M. van den Boogaard, P. Pickkers, J. Donnelly, 2014, PloS one.

Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.

I. Nováková, B. D. de Pauw, J. Donnelly, 1990, Bone marrow transplantation.

Monitoring cyclosporine using blood drawn via a central venous catheter

J. Donnelly, A. Schattenberg, N. Blijlevens, 2003, Bone Marrow Transplantation.

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

M. Arendrup, J. Donnelly, M. Cuenca‐Estrella, 2009, Antimicrobial Agents and Chemotherapy.

The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status.

M. Netea, T. Feuth, T. Plantinga, 2010, Clinical immunology.

Continuous non-invasive monitoring of the skin temperature of HSCT recipients

J. Donnelly, C. Potting, N. Blijlevens, 2009, Supportive Care in Cancer.

How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient.

J. Donnelly, C. Potting, N. Blijlevens, 2011, European journal of cancer care.

Lymphocyte subsets, granulocyte-colony-stimulating factor responsiveness and post-stem cell transplantation infections: mucositis is the underestimated confounder?

J. Donnelly, N. Blijlevens, W. J. van der Velden, 2012, Cytotherapy.

Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant

J. Donnelly, N. Blijlevens, B. Pauw, 2005, Bone Marrow Transplantation.

Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology.

J. Donnelly, J. M. van den Ouweland, A. Beijers, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Ceftazidime as first-line therapy for fever in acute leukaemia.

R. Marcus, D. Catovsky, J. Goldman, 1985, The Journal of infection.

EUCAST technical note on anidulafungin.

M. Arendrup, J. Donnelly, M. Cuenca‐Estrella, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Deferasirox as adjunctive therapy for mucormycosis.

J. Donnelly, M. Lahav, 2012, The Journal of antimicrobial chemotherapy.

Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients

J. Donnelly, N. Blijlevens, A. Herbers, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Prevention of infection in acute leukemia.

W. Gaus, B. D. de Pauw, J. Donnelly, 1990, Haematology and blood transfusion.

Bacteraemia caused by Stomatococcus mucilaginosus in a granulocytopenic patient with acute lymphocytic leukaemia.

I. Nováková, J. Donnelly, H. Muytjens, 1989, The Netherlands journal of medicine.

A Novel Antifungal Strategy

M. Klepser, J. Perfect, G. Parameswaran, 2010 .

Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients.

H. Fujii, E. Heineman, W. Buurman, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.

J. Severens, R. de Groot, A. Ament, 2007, The Journal of antimicrobial chemotherapy.

Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition

J. Meis, B. D. de Pauw, J. Donnelly, 2002, Transplant infectious disease : an official journal of the Transplantation Society.

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation

J. Donnelly, R. ter Heine, N. Blijlevens, 2023, The Journal of antimicrobial chemotherapy.

Providing oral care in haematological oncology patients: nurses' knowledge and skills.

T. van Achterberg, J. Donnelly, C. Potting, 2008, European Journal of Oncology Nursing.

Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients

J. Donnelly, N. Blijlevens, B. Depauw, 2005, Bone Marrow Transplantation.

Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance

J. Donnelly, 2009 .

Reply to Miceli and Anaissie

J. Donnelly, P. Verweij, R. Klont, 2007 .

Illness in Travelers Visiting Friends and Relatives: What Can Be Concluded?

J. Donnelly, P. Verweij, R. Klont, 2007 .

Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy?

B. D. de Pauw, J. Donnelly, J. Donnelly, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection in the neutropenic and haematopoietic stem cell transplant recipient

J. Donnelly, J. Peter Donnelly, 2000, Current opinion in infectious diseases.

Issues in antifungal stewardship: an opportunity that should not be lost

Y. Mehta, B. Tarai, A. Chakrabarti, 2016, The Journal of antimicrobial chemotherapy.

[Invasive zygomycosis in patients treated for haematological malignancies].

J. Donnelly, P. Verweij, N. Blijlevens, 2007, Nederlands tijdschrift voor geneeskunde.

Limitations of box-plots in summarizing MIC data.

J. Donnelly, 1994, The Journal of antimicrobial chemotherapy.

Software for Dosage Individualization of Voriconazole for Immunocompromised Patients

R. Jelliffe, M. Neely, J. Donnelly, 2013, Antimicrobial Agents and Chemotherapy.

Describing and comparing in-vitro antimicrobial activity by the box-plot technique.

J. Donnelly, 1992, The Journal of antimicrobial chemotherapy.

Treatment of fungal infections in surgical patients using conventional antifungals.

B. Kullberg, B. D. de Pauw, J. Donnelly, 1999, Journal of chemotherapy.

Patientsfor Immunocompromised Software for Dosage Individualization of

M. Neely, J. Donnelly, W. Hope, 2014 .

Standardization of Aspergillus PCR diagnosis

J. Loeffler, J. Donnelly, R. Barnes, 2012, Bone Marrow Transplantation.

EUCAST breakpoints for antifungals.

M. Arendrup, J. Donnelly, M. Cuenca‐Estrella, 2010, Drug news & perspectives.

Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy.

J. Donnelly, P. Verweij, N. Blijlevens, 2011, Medical mycology.

Symptoms and diagnosis of nosocomial fungal infections -- state-of-the-art.

J. Donnelly, 2002, European Journal of Medical Research.

Aspergillus tracheobronchitis after allogeneic bone marrow transplantation

J. Donnelly, S. Assen, P. Verweij, 2000, Bone Marrow Transplantation.

Host impairments in patients with neoplastic diseases.

B. Kullberg, B. D. de Pauw, J. Donnelly, 1998, Cancer treatment and research.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

H. Einsele, P. Hauser, W. Melchers, 2016, The Journal of antimicrobial chemotherapy.

Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients

J. Donnelly, N. Blijlevens, A. Herbers, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis.

J. Loeffler, C. Mengoli, J. Donnelly, 2009, The Lancet. Infectious diseases.

European expert opinion on the management of invasive candidiasis in adults.

J. Vincent, J. Meis, T. Calandra, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Issues in genetic association studies: limitations of statistical analysis and biological plausibility

T. Feuth, J. Donnelly, N. M. Blijlevens, 2011, Bone Marrow Transplantation.

The Evidence Supporting the Revised EORTC/MSGERC Definitions for Invasive Fungal Infections.

J. Donnelly, P. Pappas, S. Chen, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The role of antifungal treatment in hematology

J. Donnelly, J. Maertens, M. Nucci, 2012, Haematologica.

Critical Stages of Extracting DNA from Aspergillus fumigatus in Whole-Blood Specimens

W. Melchers, J. Loeffler, P. White, 2010, Journal of Clinical Microbiology.

Reply to Luppi et al

L. Pagano, J. Wingard, J. Donnelly, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safe living after hematopoietic cell transplantation

K. Sepkowitz, T. Palmore, D. Yokoe, 2009, Bone Marrow Transplantation.